De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity

Research output: Patent

Abstract

A de-epitoped alpha gliadin is provided. Methods of generating same and uses thereof are also provided.

US Patent App. 17/624,600

@misc{2314c95f45764898be379d817c6a815e,

title = "De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity",

abstract = "A de-epitoped alpha gliadin is provided. Methods of generating same and uses thereof are also provided.",

author = "Yanay Ofran and Moshe Ben-David and Assaf Biran and Shiri Zakin and Garber, \{Orly MARCU\} and Anna Chuprin",

note = "US Patent App. 17/624,600; US20220251148A1",

year = "2022",

month = aug,

day = "1",

language = "אנגלית",

publisher = "Google Patents,",

type = "Patent",

}

TY - PAT

T1 - De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity

AU - Ofran, Yanay

AU - Ben-David, Moshe

AU - Biran, Assaf

AU - Zakin, Shiri

AU - Garber, Orly MARCU

AU - Chuprin, Anna

N1 - US Patent App. 17/624,600

PY - 2022/8/1

Y1 - 2022/8/1

N2 - A de-epitoped alpha gliadin is provided. Methods of generating same and uses thereof are also provided.

AB - A de-epitoped alpha gliadin is provided. Methods of generating same and uses thereof are also provided.

UR - https://patents.google.com/patent/US20220251148A1/en

M3 - ???researchoutput.researchoutputtypes.patent.patent???

M1 - US20220251148A1

PB - Google Patents,

ER -